Quantiscope is an AI-driven public benefit corporation developing automated image analysis for drug discovery, bio-processing, and bio-manufacturing. Its PhenotypIQ enterprise platform applies machine learning to transform microscopic images into quantifiable phenotypic data. The company was launched from the Broad Institute of Harvard and MIT and operates from the Altitude Lab incubator in Salt Lake City, Utah.
PhenotypIQ provides team-oriented dashboards that identify cells and subcellular structures in brightfield and stained high-content images without labeling or treatment conditioning. The platform extracts cellular feature signatures and aggregates them through cloud-based graphics processing into predictive rankings of therapeutic candidates and manufactured batch viability. Quantiscope serves pharmaceutical and biotechnology researchers seeking faster and safer therapy development.